Bivin & Associates’s Viatris VTRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
$0 Sell
44
-400
-90% -$4.38K ﹤0.01% 372
2022
Q1
$5K Hold
444
﹤0.01% 213
2021
Q4
$6K Buy
+444
New +$5.93K 0.01% 210

Other funds holding VTRS

Bivin & Associates's VTRS Position: Q2 2022 in Review

Bivin & Associates reduced its Viatris (VTRS) stake by 90% in Q2 2022, selling an estimated $4.38K and leaving 44 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #372.

Bivin & Associates first reported a position in VTRS in Q4 2021 and has held it in 3 quarters since. The position peaked at $6K in Q4 2021. 1,011 funds tracked by Wall St. Rank hold VTRS as of Q2 2022.

  • Bivin & Associates held 44 shares of Viatris worth $0 as of Q2 2022.
  • Bivin & Associates sold 400 Viatris shares in Q2 2022, an estimated $4.38K.
  • Viatris made up ﹤0.01% of Bivin & Associates's portfolio in Q2 2022, its #372 holding.
  • Bivin & Associates first reported a position in Viatris in Q4 2021 and has held it in 3 quarters since.
  • Bivin & Associates's Viatris position peaked at $6K in Q4 2021.
  • 1,011 funds tracked by Wall St. Rank held Viatris as of Q2 2022.

Based on Bivin & Associates's 13F filing for Q2 2022, filed 11 Aug 2022.